Quick Answer
Q32 Bio Inc. reported Total Revenue of $53.74 million for fiscal year 2025.
Q32 Bio Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $53.74M | — |
| 2024 | $0.00 | +100.0% |
| 2023 | -$6.65M | -307.3% |
| 2022 | $3.21M | -90.6% |
| 2021 | $33.97M | +1157.3% |
| 2020 | $2.70M | +62.2% |
| 2019 | $1.67M | -54.8% |
| 2018 | $3.68M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $0.00 | -100.0% | — |
| June 30, 2024 | $0.00 | -100.0% | — |
| March 31, 2024 | $0.00 | -100.0% | -100.0% |
| September 30, 2023 | $1.86M | +131.8% | -42.0% |
| June 30, 2023 | $3.21M | +299.6% | +8.8% |
| March 31, 2023 | $2.95M | +267.5% | +267.5% |
| September 30, 2022 | $802.0K | -52.2% | +0.0% |
| June 30, 2022 | $802.0K | -63.3% | +0.0% |
- Over the 2018–2025 period, Q32 Bio Inc.’s total revenue has grown by 1358.7% (from $3.68 million to $53.74 million).
- The most recent figure is from Q32 Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: